Marine actinomycete crude extracts with potent TRAIL-resistance overcoming activity against breast cancer cells

Almasan, 2003, Apo2L/TRAIL: Apoptosis signaling, biology, and potential for cancer therapy, Cytokine Growth Factor Rev, 14, 337, 10.1016/S1359-6101(03)00029-7

Micheau, 2013, Death receptors as targets in cancer, Br J Pharmacol, 169, 1723, 10.1111/bph.12238

Peter, 2003, The CD95(APO-1/Fas) DISC and beyond, Cell Death Differ, 10, 26, 10.1038/sj.cdd.4401186

Kelley, 2004, Targeting death receptors in cancer with Apo2L/TRAIL, Curr Opin Pharmacol, 4, 333, 10.1016/j.coph.2004.02.006

Falschlehner, 2007, TRAIL signalling: Decisions between life and death, Int J Biochem Cell Biol, 39, 1462, 10.1016/j.biocel.2007.02.007

Griffith, 1998, TRAIL: A molecule with multiple receptors and control mechanisms, Curr Opin Immunol, 10, 559, 10.1016/S0952-7915(98)80224-0

Zhu, 2004, Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor I through distinct mechanisms, Mol Ther, 9, 666, 10.1016/j.ymthe.2004.02.007

Greco, 2008, Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer, Lung Cancer, 61, 82, 10.1016/j.lungcan.2007.12.011

Henson, 2008, The role of TRAIL death receptors in the treatment of hematological malignancies, Leuk Lymphoma, 49, 27, 10.1080/10428190701713655

Humphreys, 2008, Trail receptors: Targets for cancer therapy, Adv Exp Med Biol, 615, 127, 10.1007/978-1-4020-6554-5_7

Ndozangue-Touriguine, 2008, A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma, Oncogene, 27, 6012, 10.1038/onc.2008.197

Thorburn, 2008, TRAIL receptor-targeted therapeutics: Resistance mechanisms and strategies to avoid them, Drug Resist Updat, 11, 17, 10.1016/j.drup.2008.02.001

Mahalingam, 2009, TRAIL receptor signalling and modulation: Are we on the right TRAIL?, Cancer Treat Rev, 35, 280, 10.1016/j.ctrv.2008.11.006

Kaufmann, 2012, Fas death receptor signalling: Roles of Bid and XIAP, Cell Death Differ, 19, 42, 10.1038/cdd.2011.121

Srivastava, 2001, TRAIL/Apo-2L: Mechanisms and clinical applications in cancer, Neoplasia, 3, 535, 10.1038/sj.neo.7900203

Morizot, 2011, Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level, Cell Death Differ, 18, 700, 10.1038/cdd.2010.144

Jacquemin, 2012, Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells, Haematologica, 97, 38, 10.3324/haematol.2011.046466

Morlé, 2015, Hyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion, Cell Death Dis, 6, e1633, 10.1038/cddis.2015.12

Blunt, 2006, Marine natural products, Nat Prod Rep, 23, 26, 10.1039/b502792f

Mayer, 2007, Marine pharmacology in 2003-4: Marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action, Comp Biochem Physiol C Toxicol Pharmacol, 145, 553, 10.1016/j.cbpc.2007.01.015

Williams, Panning for chemical gold: Marine bacteria as a source of new therapeutics, Trends Biotechnol, 27, 45, 10.1016/j.tibtech.2008.10.005

Blunt, 2009, Marine natural products, Nat Prod Rep, 26, 170, 10.1039/b805113p

Fenical, 2002, Marine microorganisms as a developing resource for drug discovery, Pharm News, 9, 489

Abdelfattah, 2013, A new bioactive aminophenoxazinone alkaloid from a marine-derived actinomycete, Nat Prod Res, 27, 2126, 10.1080/14786419.2013.793686

Abdelfattah, 2016, New phenazine analogues from Streptomyces sp. IFM 11694 with TRAIL resistance-overcoming activities, J Antibiot (Tokyo), 69, 446, 10.1038/ja.2015.129

Abdelfattah, 2012, Yoropyrazone, a new naphthopyridazone alkaloid isolated from Streptomyces sp. IFM 11307 and evaluation of its TRAIL resistance-overcoming activity, J Antibiot (Tokyo), 65, 245, 10.1038/ja.2012.11

Abdelfattah, 2016, Sulfotanone, a new alkyl sulfonic acid derivative from Streptomyces sp. IFM 11694 with TRAIL resistance-overcoming activity, J Nat Med, 70, 266, 10.1007/s11418-015-0951-3

Abdelfattah, 2011, New pyranonaphthoquinones and a phenazine alkaloid isolated from Streptomyces sp. IFM 11307 with TRAIL resistance-overcoming activity, J Antibiot (Tokyo), 64, 729, 10.1038/ja.2011.85

Abdelfattah, 2010, Izumiphenazines A-C: Isolation and structure elucidation of phenazine derivatives from Streptomyces sp. IFM 11204, J Nat Prod, 73, 1999, 10.1021/np100400t

Elmallah, 2015, Marine drugs regulating apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), Mar Drugs, 13, 6884, 10.3390/md13116884

Hayakawa, 1987, Humic acid-vitamin agar, a new medium for the selective isolation of soil actinomycetes, J Ferment Technol, 65, 501, 10.1016/0385-6380(87)90108-7

Kuester, 1964, Selection of media for the isolation of streptomycetes, Nature, 202, 928, 10.1038/202928a0

Kieser, 2000, Practical Streptomyces Genetics, 2nd

Abdelfattah, 2016, Isolation and characterization of marine-derived actinomycetes with cytotoxic activity from the Red Sea coast, Asian Pac J Trop Biomed, 6, 651, 10.1016/j.apjtb.2016.06.004

LeBlanc, 2003, Apo2L/TRAIL and its death and decoy receptors, Cell Death Differ, 10, 66, 10.1038/sj.cdd.4401187

Takahashi, 2003, Isolation of new actinomycete strains for the screening of new bioactive compounds, J Gen Appl Microbiol, 49, 141, 10.2323/jgam.49.141

Blunt, 2007, Marine natural products, Nat Prod Rep, 24, 31, 10.1039/b603047p

Van Slambrouck, 2007, Effects of crude aqueous medicinal plant extracts on growth and invasion of breast cancer cells, Oncol Rep, 17, 1487

Ferretti, 2007, Effects of Agelas oroides and Petrosia ficiformis crude extracts on human neuroblastoma cell survival, Int J Oncol, 30, 161

Oliveras-Ferraros, 2011, Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3, Int J Oncol, 38, 1533

Szliszka, 2011, Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis, Int J Oncol, 38, 941

Abdelhamed, 2013, Identification of plant extracts sensitizing breast cancer cells to TRAIL, Oncol Rep, 29, 1991, 10.3892/or.2013.2293

Lee, 2013, A formulated red ginseng extract upregulates CHOP and increases TRAIL-mediated cytotoxicity in human hepatocellular carcinoma cells, Int J Oncol, 43, 591, 10.3892/ijo.2013.1964

Thorburn, 2004, Death receptor-induced cell killing, Cell Signal, 16, 139, 10.1016/j.cellsig.2003.08.007

Rao, 1996, Lamin proteolysis facilitates nuclear events during apoptosis, J Cell Biol, 135, 1441, 10.1083/jcb.135.6.1441

Sano, 2013, ER stress-induced cell death mechanisms, Biochim Biophys Acta, 1833, 3460, 10.1016/j.bbamcr.2013.06.028